BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Novelli L, Lubrano E, Venerito V, Perrotta FM, Marando F, Curradi G, Iannone F. Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk. Front Med (Lausanne) 2021;8:737079. [PMID: 34631754 DOI: 10.3389/fmed.2021.737079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tillett W, Ogdie A, Passey A, Gorecki P. Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study. RMD Open 2023;9. [PMID: 36650006 DOI: 10.1136/rmdopen-2022-002533] [Reference Citation Analysis]
2 Lubrano E, Scriffignano S, Perrotta FM. Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatol Ther 2022. [DOI: 10.1007/s40744-022-00514-0] [Reference Citation Analysis]
3 Venerito V, Lopalco G, Abbruzzese A, Colella S, Morrone M, Tangaro S, Iannone F. A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab. Front Immunol 2022;13:917939. [DOI: 10.3389/fimmu.2022.917939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Al-homood I, Alunizi S, Alshanqeeti A, Alenzi K. Psoriatic arthritis: Saudi retrospective observational study of manifestations and treatments. Ann Rheumatol Autoimmun 2022;2:53. [DOI: 10.4103/ara.ara_14_22] [Reference Citation Analysis]
5 Queiro R, Coto P, González-Lara L, Coto E. Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease. Int J Mol Sci 2021;22:13004. [PMID: 34884808 DOI: 10.3390/ijms222313004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]